Rheumnow Podcast
Dr Jack Cush reviews the news, journal reports and regulatory decisions from the past week on RheumNow.com
Latest episodes
Oct 18, 2024 • 21min
ANA+ consult (10.18.2024)
Dr. Jack Cush reviews the news and journal articles from this past week on RheumNow.com
Oct 11, 2024 • 25min
Dot the "i," Cross the "t" (10.11.2024)
Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com. Todays reports suggest where to look for help, especially with regard to pain.
Oct 4, 2024 • 23min
Stop Counting Bugs (10.4.2024)
Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com -- This weeks rants include the microbiome, PsA treatment choices and fishing for P-values in research.
Oct 1, 2024 • 18min
RA Risk Radar: Heart Disease, Infection, and Malignancy Sponsored by AbbVie Medical Affairs
Rheumatologists Dr. Jeffrey Curtis and Dr. Jon Giles discuss the risk of comorbidities that can occur as a consequence of uncontrolled inflammation in RA
Sep 27, 2024 • 26min
Which One is the Loneliest Number (9.27.2024)
Dr. Jack Cush reviews the regulatory approvals, announcements, guidelines and interesting journal articles from the past week on RheumNow.com. When not to use muscle relaxants, how frequent is loneliness in RA/PsA/SpA and when to refer patients with Still's disease..
Register for RheumNow Live Feb 8 & 9th 2025 here "Great Rheums go to Phenomenal Meetings like this"!
Sep 20, 2024 • 26min
I Cant Treat Ugly (9.20.2024)
Dr. Jack Cush reviews the news, journal articles and a new FDA approval for EGPA, this week on the Podcast.
Sep 13, 2024 • 22min
Systemic Sclerosis Insights (9.13.2024)
Dr. Jack Cush reviews the news and journal articles from this past week on RheumNow.com.
Sep 6, 2024 • 22min
Linger on the Fingers (9.6.2024)
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com.
This week with a focus on fingers and better prescriptive follow through.
Aug 31, 2024 • 8min
Earlier treatment with biologics to reduce the risk of organ damage in systemic lupus erythematosus (SLE) Sponsored by GSK US Medical Affairs
Learn about the importance of reducing organ damage and corticosteroid-associated toxicity in SLE, and how biologics may help to change the course of the disease by targeting its underlying mechanisms.
Aug 30, 2024 • 23min
Running with Data (8.30.2024)
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com - including tips on steroids, MAS, and myositis testing.
